跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atorvas Tablet 20mg - NPRA Drug Approval Details
Approvals
/
NPRA
/
Atorvas Tablet 20mg
Approved
STANDARD
Atorvas Tablet 20mg
RANBAXY (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
4238b25e29c65f94
Company
RANBAXY (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
4238b25e29c65f94
Drug Approval Npra Name
Atorvas Tablet 20mg
Product Name
Atorvas Tablet 20mg
Registration Number
MAL06081187AZ
Holder Company Name
RANBAXY (MALAYSIA) SDN. BHD.
Holder Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Holder Address
LOT 23, BAKAR ARANG INDUSTRIAL ESTATE 08000 SUNGAI PETANI MALAYSIA
Holder Phone
04 4220660/04 4220661
Manufacturer Company Name
RANBAXY (MALAYSIA) SDN. BHD.
Manufacturer Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Manufacturer Address
LOT 23, BAKAR ARANG INDUSTRIAL ESTATE 08000 SUNGAI PETANI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL06081187AZ
Version
1751614560
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
4238b25e29c65f94
Type
Standard
Source
Official Source
Back to NPRA Approvals